HE News Icon

HEOR News Roundup

Tuesday, Sept. 29, 2020 | Issue 521

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

[Webinar] How Can Adaptive Designs and Master Protocols Enhance Your Oncology Trials?

While oncology trials comprise a large proportion of current research pipelines, conventional oncology development programs are frequently expensive, inefficient, and plagued by high failure rates.

Read More

ICER Condemns Monopoly Pricing of Trikafta Despite High Marks for Efficacy


COVID-19 Underscores Urgent Need for Real-world Data


Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach


A Little More Spending Is Not the End of the World

 
HEOR news icon
Featured Events

   Webinars

 

Workshop: Digital Advances and Publication Planning: Current Practices and Future Directions

September 30

   
 

Maintaining Market Access Through a Pandemic; 6-months on

October 1

Spotlight

 
 
Syndicated Reports
   
HTA in Europe: Key Success Factors for Positive HTA Recommendations
 
Paying for Digital Health: Payer Insights
 
White Papers
   
Patient Centricity
 
How to Excel at Next Generation Trial Execution
 
 
  Analyst / Manager- Reimbursement Strategy Vice President/ Senior Vice President, Business Development Senior Analyst, Real World Evidence Solutions Research Associate III/Senior Research Associate – Data Collection – Peri- and Post-Approval Studies  
 
 
 
     
 
 

Share this newsletter!